Intravenous Infusions Limited Reports Financial Results for the Period Ended June 30, 2016
Intravenous Infusions Limited reported financial results for the period ended June 30, 2016. For the period, the company reported revenue of GHS 4,781,354 against GHS 2,923,740 a year ago. Operating profit was GHS 817,815 compared to operating loss of GHS 1,008,774 a year ago. Net profit before tax was GHS 596,981 compared to loss of GHS 1,270,608 a year ago. Net profit for the year was GHS 485,047 against loss of GHS 1,270,608 a year ago. Net from operating activities was GHS 4,670,417 compared to net cash used in operating activities of GHS 1,004,848 a year ago. Purchase of property, plant and equipment was GHS 361,382 compared to GHS 30,977 a year ago.